Search
for
Sort by
Research 541–570 of 1000+
- Tofacitinib for the treatment of alopecia areata and variants in adolescents
- Extensive alopecia areata is reversed by IL-12/IL-23p40 cytokine antagonism
- Efficacy of topical tofacitinib in promoting hair growth in non-scarring alopecia: possible mechanism via VEGF induction
- Efficacy of Postbiotics in a PRP-Like Cosmetic Product for the Treatment of Alopecia Area Celsi: A Randomized Double-Blinded Parallel-Group Study
- Virtual Bioequivalence Assessment of Ritlecitinib Capsules with Incorporation of Observed Clinical Variability Using a Physiologically Based Pharmacokinetic Model
- Experience with oral tofacitinib in severe alopecia areata with different clinical responses
- Comparison of the Treatment Outcome of Oral Tofacitinib with Other Conventional Therapies in Refractory Alopecia Totalis and Universalis: A Retrospective Study
- Real-World Evidence for Baricitinib in the Treatment of Atopic Dermatitis and Alopecia Areata: Systematic Literature Review 2020–2023
- Treatment of Alopecia Areata with Oral JAK Inhibitor : Focusing on Clinical Outcomes with Baricitinib
- How Long to Treat to Achieve Desired Treatment Outcomes with Baricitinib 4 mg in Severe Alopecia Areata: Evidence-based Approach
- Efficacy and safety of tofacitinib in patients with alopecia areata
- Comparative Evaluation of Oral Baricitinib and Tofacitinib in Alopecia Areata: A Retrospective Cohort Study Based on SALT Scores
- Rationale and Design of a Novel, Phase 3, External and Synthetic Placebo-Controlled Clinical Trial of Ritlecitinib 50 mg and 100 mg for Alopecia Areata
- Treatment of alopecia areata with JAK inhibitors: a review of the literature
- Effectiveness of baricitinib in severe alopecia areata in real life: a retrospective study of 87 patients
- Unexpected Extensive Hair Whitening Following Baricitinib Treatment for Alopecia Universalis: A Case Report and Mechanistic Insights
- Ritlecitinib in severe alopecia areata: a profile of its use
- Turning JAK STATic, a peek into the future of dermatology therapeutics
- ORAL TOFACITINIB IN MODERATE AND SEVERE ALOPECIA AREATA: CASE SERIES OF 14 PATIENTS
- Drug pipeline 2Q22 — a downturn in approvals
- British Hair and Nail Society
- New therapies for alopecia areata
- El papel de los inhibidores de JAK en la alopecia areata: revisión de la literatura
- Topical 2% tofacitinib for children with alopecia areata, alopecia totalis, and alopecia universalis
- Alopecia in patients treated with molecularly targeted anticancer therapies
- Tofacitinib therapy for children with severe alopecia areata
- Treatment of alopecia areata in pre‐adolescent children with oral tofacitinib: A retrospective study
- Integrated safety analysis of baricitinib in adults with severe alopecia areata from two randomized clinical trials
- Combination tofacitinib and oral minoxidil treatment for severe alopecia areata
- Aromatic plants as cosmeceuticals: benefits and applications for skin health